Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
President Donald Trump urged a coalition of nations to dispatch warships to secure the Strait of Hormuz, signaling a ...
Amazon's latest move highlights a broader theme: AI investment can lift near-term costs even as revenue opportunities...
Explore how Fluent's Q1 2026 earnings could shape its year ahead. This article breaks down revenue trends, margins, a...
A high-stakes portfolio shuffle by a famed activist investor grabbed headlines. This piece breaks down what happened,...
SpaceX is lining up what could be the largest IPO in U.S. history, targeting about $75 billion by selling hundreds of...
Axon Enterprise stock popped as investors weighed the company’s expanding product lineup, software growth, and a grow...
Stocks hover near record highs as earnings show resilience, but analysts warn that the gap between prices and profits...
Three clear visions for AMD in 2026, from AI-driven demand to capital returns. Learn what could move the stock and ho...
A deep dive into MiB: Bill Gurley, Benchmark—how a pioneering VC built a team culture, backed Uber and other giants, ...
When a major fund buys more while a stock falls, it sets up a compelling investing puzzle. This piece explains what t...
U.S. consumer discretionary stocks rise as demand improves in March 2026. Analysts cite pricing power and resilient c...